|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-8-30
|
|
pubmed:abstractText |
This report describes the use of a novel sensitive and specific ELISA for the measurement of human fibrinogen-like protein 2 (FGL2/fibroleukin), a novel effector of natural regulatory T (Treg) cells, to predict the course of chronic hepatitis C viral infection (HCV).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:AdeyiOyedele AOA,
pubmed-author:ClarkDavid ADA,
pubmed-author:FoersterKatharinaK,
pubmed-author:GrantDavid RDR,
pubmed-author:HeathcoteElizabeth JEJ,
pubmed-author:HelmyAhmedA,
pubmed-author:KhattarRamziR,
pubmed-author:LevyGary AGA,
pubmed-author:PhillipsMelville JMJ,
pubmed-author:RennerEberhard LEL,
pubmed-author:SelznerNaziaN,
pubmed-author:ShalevItayI,
pubmed-author:WongKit ManKM,
pubmed-author:WongPui-YuenPY,
pubmed-author:ZhuYiY
|
|
pubmed:copyrightInfo |
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
608-15
|
|
pubmed:meshHeading |
pubmed-meshheading:20615566-Adult,
pubmed-meshheading:20615566-Aged,
pubmed-meshheading:20615566-Biological Markers,
pubmed-meshheading:20615566-Case-Control Studies,
pubmed-meshheading:20615566-Female,
pubmed-meshheading:20615566-Fibrinogen,
pubmed-meshheading:20615566-Hepatitis C, Chronic,
pubmed-meshheading:20615566-Humans,
pubmed-meshheading:20615566-Liver Diseases, Alcoholic,
pubmed-meshheading:20615566-Male,
pubmed-meshheading:20615566-Middle Aged,
pubmed-meshheading:20615566-Predictive Value of Tests,
pubmed-meshheading:20615566-Sensitivity and Specificity,
pubmed-meshheading:20615566-Severity of Illness Index
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection.
|
|
pubmed:affiliation |
Multi Organ Transplant Program, University Health Network, University of Toronto, Toronto, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
